Why the study?
Little is known about reactions to LV stimulation and whether they are affected by QRS duration, morphology, LV substrate, or choice of electrode pair in patients receiving CRT.
How does left ventricular paced activation relate to intrinsic activation delay and electrical substrate in heart failure patients with LBBB receiving CRT?
How does left ventricular paced activation relate to intrinsic activation delay and electrical substrate in heart failure patients with LBBB receiving CRT?
LV-paced conduction times in CRT patients with LBBB are unpredictable based on intrinsic activation delay and vary significantly by electrode pair, highlighting the need for individualized CRT optimization.
Answers are grounded in this paper and cite their sources.
LV stimulation responses in CRT may vary by QRS morphology and substrate; leaves open optimized electrode selection pending prospective trials.
Background Cardiac resynchronization therapy (CRT) uses left ventricular (LV) pacing to restore rapid synchronized LV activation when it is delayed in patients with myocardial disease. Objective Although intrinsic LV activation delays are understood, little is known about reactions to LV stimulation and whether they are affected by QRS duration (QRSd), morphology, LV substrate, or choice of electrode pair. The purpose of this study was to test these interactions. Methods In 120 heart failure patients with left bundle branch block (LBBB) and QRS >120 ms receiving CRT with quadripolar LV leads, device-based measurements of intrinsic activation delay (qLV) and paced inter- (and intra-) LV conduction times were evaluated at the proximal and distal LV bipoles. Results During intrinsic conduction, qLV varied little between the proximal and distal pairs in patients with LBBB (n = 120; age 68 ± 11 years; 63% male; ejection fraction 25% ± 7%; 33% ischemic cardiomyopathy; QRSd 162 ± 19 ms). A minority (30%) had conduction barriers (ie, gradients) (ΔqLV 29 ± 8 ms vs 9 ± 5 ms in patients without gradients; P <.01), which occurred equally in ischemic and nonischemic patients. A majority were functional (and not scar-mediated), as they resolved with pacing in most patients (75%). Importantly, LV-paced conduction times were unrelated to baseline QRS morphology (LBBB 166 ± 30 ms vs RBBB control 172 ± 30 ms; P = NS), longer than intrinsic conduction (166 ± 30 ms vs 129 ± 28 ms; P <.01), and varied significantly by electrode pair (ie, small distances) and etiology. Correlation between intrinsic activation delay (qLV) and LV-paced conduction time was poor (R 2 = 0.278; P <.05). Conclusion LV-paced effect, which is core to CRT, is unpredictable based on conventionally used measures and should be considered during CRT optimization.
No takes yet. Share an insight, caveat, or question.
Wisnoskey et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: